News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Virginia Commonwealth University Scientists Report Anti-Inflammatory Effect of Aradigm Corporation (ARDM)'s Inhaled Liposomal Ciprofloxacin


10/16/2012 10:07:55 AM

HAYWARD, Calif.--(BUSINESS WIRE)--Today at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS) in Chicago, IL, scientists from the Virginia Commonwealth University (Richmond, VA) will report findings about the anti-inflammatory effects of Aradigm Corporation’s (OTCBB:ARDM) (the “Company”) inhaled ciprofloxacin in human bronchial lung cells stimulated by the lipopolysaccharide (LPS) produced by Pseudomonas aeruginosa.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES